Rasilez and Eye disorder - a phase IV clinical study of FDA data

Summary:

Eye disorder is reported as a side effect among people who take Rasilez (aliskiren hemifumarate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lipitor, and have Abdominal pain upper.

The phase IV clinical study analyzes which people have Eye disorder when taking Rasilez. It is created by eHealthMe based on reports of 5,976 people who have side effects when taking Rasilez from the FDA, and is updated regularly.

What is Rasilez?

Rasilez has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 6,001 Rasilez users. Check the latest studies of Rasilez.

What is Eye disorder?

Eye disorder is found to be associated with 1,351 drugs and 1,453 conditions by eHealthMe. Check the latest studies of Eye disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

5,976 people reported to have side effects when taking Rasilez.
Among them, 22 people (0.37%) have Eye disorder.

Among these 22 people:

How long have people been on Rasilez when they have Eye disorder? *

What is the gender of people who have Eye disorder when taking Rasilez? *

female: 86.36 %
male: 13.64 %

What is the age of people who have Eye disorder when taking Rasilez? *

What are other drugs people take besides Rasilez? *

What are other side effects people have besides Eye disorder? *

Feeling Abnormal: 6 people, 27.27%
Burning Sensation: 6 people, 27.27%
Oropharyngeal Pain: 6 people, 27.27%
Rashes (redness): 6 people, 27.27%
Diarrhea: 6 people, 27.27%
Back Pain: 6 people, 27.27%
Cataract (clouding of the lens inside the eye): 6 people, 27.27%
Nausea And Vomiting: 5 people, 22.73%
Chest Pain: 5 people, 22.73%
Limb Discomfort (discomfort in leg): 4 people, 18.18%

What are the existing conditions these people have? *

Visual Acuity Reduced (reduced clearness of vision): 2 people, 9.09%
Pemphigoid (tense blisters on the skin): 2 people, 9.09%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 2 people, 9.09%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 9.09%
Headache (pain in head): 2 people, 9.09%
Diabetes: 2 people, 9.09%
Abdominal Pain Upper: 2 people, 9.09%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 4.55%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.55%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Rasilez and have Eye disorder?

- Check whether Eye disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rasilez:

Rasilez (6,001 reports)

Eye disorder treatments and more:

Eye disorder (40,666 reports)

Browse all side effects of Rasilez:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye disorder:

Eye disorder (1,351 drugs)

Browse all the conditions that are associated with Eye disorder:

Eye disorder (1,453 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate (the active ingredients of Rasilez) and Rasilez (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.